Biotech Values

[exwannabe]

"patients in the Davanat trial had a median survival of 6.7 months"

WOW!

I considered this possibility and didn't check into it because this is really past hype and into pure lies. It's not part of a sale or other commercial transaction, so you can't call fraud.

If I was the SEC though, I would call them on this one. The safe habour statement does not cover pure lies. And if they used extend to describe absolute trial survival, that is a LIE.

Of course, the pussy whipped SEC will never take action in such cases. Just like those two onc. biotechs saying their drug is approved for commercial use in Switzerland when they really have something like an IND and an inport/export license. Those 2 PR's were flagrant lies.